Cargando…

Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway

AIMS: Sevoflurane preconditioning (SPC) results in cerebral ischemic tolerance; however, the mechanism remains unclear. Promoting microglia/macrophages polarization from pro‐inflammatory state to anti‐inflammatory phenotype has been indicated as a potential treatment target against ischemic stroke....

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Min, Sun, Sisi, Wang, Jin, Dong, Beibei, Yang, Qianzi, Tian, Li, Dong, Hailong, Wang, Shiquan, Hou, Wugang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504524/
https://www.ncbi.nlm.nih.gov/pubmed/34370899
http://dx.doi.org/10.1111/cns.13715
_version_ 1784581335590895616
author Cai, Min
Sun, Sisi
Wang, Jin
Dong, Beibei
Yang, Qianzi
Tian, Li
Dong, Hailong
Wang, Shiquan
Hou, Wugang
author_facet Cai, Min
Sun, Sisi
Wang, Jin
Dong, Beibei
Yang, Qianzi
Tian, Li
Dong, Hailong
Wang, Shiquan
Hou, Wugang
author_sort Cai, Min
collection PubMed
description AIMS: Sevoflurane preconditioning (SPC) results in cerebral ischemic tolerance; however, the mechanism remains unclear. Promoting microglia/macrophages polarization from pro‐inflammatory state to anti‐inflammatory phenotype has been indicated as a potential treatment target against ischemic stroke. In this study, we aimed to assess the effect of SPC on microglia polarization after stroke and which signaling pathway was involved in this transition. METHODS: Mouse primary microglia with SPC were challenged by oxygen‐glucose deprivation (OGD) or lipopolysaccharide (LPS), and mice with SPC were subjected to middle cerebral artery occlusion (MCAO). Then, the mRNA and protein levels of pro‐inflammatory/anti‐inflammatory factors were analyzed. GSK‐3β phosphorylation and Nrf2 nuclear translocation were measured. The mRNA and protein expression of pro‐inflammatory/anti‐inflammatory factors, neurological scores, infarct volume, cellular apoptosis, the proportion of pro‐inflammatory/anti‐inflammatory microglia/macrophages, and the generation of super‐oxidants were examined after SPC or GSK‐3β inhibitor TDZD treatment with or without Nrf2 deficiency. RESULTS: Sevoflurane preconditioning promoted anti‐inflammatory and inhibited pro‐inflammatory microglia/macrophages phenotype both in vitro and in vivo. GSK‐3β phosphorylation at Ser9 was increased after SPC. Both SPC and TDZD administration enhanced Nrf2 nuclear translocation, reduced pro‐inflammatory microglia/macrophages markers expression, promoted anti‐inflammatory markers level, and elicited a neuroprotective effect. Nrf2 deficiency abolished the promoted anti‐inflammatory microglia/macrophages polarization and ischemic tolerance induced by TDZD treatment. The reduced percentage of pro‐inflammatory positive cells and super‐oxidants generation induced by SFC or TDZD was also reversed by Nrf2 knockdown. CONCLUSIONS: Our results indicated that SPC exerts brain ischemic tolerance and promotes anti‐inflammatory microglia/macrophages polarization by GSK‐3β‐dependent Nrf2 activation, which provides a novel mechanism for SPC‐induced neuroprotection.
format Online
Article
Text
id pubmed-8504524
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85045242021-10-18 Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway Cai, Min Sun, Sisi Wang, Jin Dong, Beibei Yang, Qianzi Tian, Li Dong, Hailong Wang, Shiquan Hou, Wugang CNS Neurosci Ther Original Articles AIMS: Sevoflurane preconditioning (SPC) results in cerebral ischemic tolerance; however, the mechanism remains unclear. Promoting microglia/macrophages polarization from pro‐inflammatory state to anti‐inflammatory phenotype has been indicated as a potential treatment target against ischemic stroke. In this study, we aimed to assess the effect of SPC on microglia polarization after stroke and which signaling pathway was involved in this transition. METHODS: Mouse primary microglia with SPC were challenged by oxygen‐glucose deprivation (OGD) or lipopolysaccharide (LPS), and mice with SPC were subjected to middle cerebral artery occlusion (MCAO). Then, the mRNA and protein levels of pro‐inflammatory/anti‐inflammatory factors were analyzed. GSK‐3β phosphorylation and Nrf2 nuclear translocation were measured. The mRNA and protein expression of pro‐inflammatory/anti‐inflammatory factors, neurological scores, infarct volume, cellular apoptosis, the proportion of pro‐inflammatory/anti‐inflammatory microglia/macrophages, and the generation of super‐oxidants were examined after SPC or GSK‐3β inhibitor TDZD treatment with or without Nrf2 deficiency. RESULTS: Sevoflurane preconditioning promoted anti‐inflammatory and inhibited pro‐inflammatory microglia/macrophages phenotype both in vitro and in vivo. GSK‐3β phosphorylation at Ser9 was increased after SPC. Both SPC and TDZD administration enhanced Nrf2 nuclear translocation, reduced pro‐inflammatory microglia/macrophages markers expression, promoted anti‐inflammatory markers level, and elicited a neuroprotective effect. Nrf2 deficiency abolished the promoted anti‐inflammatory microglia/macrophages polarization and ischemic tolerance induced by TDZD treatment. The reduced percentage of pro‐inflammatory positive cells and super‐oxidants generation induced by SFC or TDZD was also reversed by Nrf2 knockdown. CONCLUSIONS: Our results indicated that SPC exerts brain ischemic tolerance and promotes anti‐inflammatory microglia/macrophages polarization by GSK‐3β‐dependent Nrf2 activation, which provides a novel mechanism for SPC‐induced neuroprotection. John Wiley and Sons Inc. 2021-08-09 /pmc/articles/PMC8504524/ /pubmed/34370899 http://dx.doi.org/10.1111/cns.13715 Text en © 2021 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Cai, Min
Sun, Sisi
Wang, Jin
Dong, Beibei
Yang, Qianzi
Tian, Li
Dong, Hailong
Wang, Shiquan
Hou, Wugang
Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway
title Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway
title_full Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway
title_fullStr Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway
title_full_unstemmed Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway
title_short Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway
title_sort sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through gsk‐3β/nrf2 pathway
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504524/
https://www.ncbi.nlm.nih.gov/pubmed/34370899
http://dx.doi.org/10.1111/cns.13715
work_keys_str_mv AT caimin sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway
AT sunsisi sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway
AT wangjin sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway
AT dongbeibei sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway
AT yangqianzi sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway
AT tianli sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway
AT donghailong sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway
AT wangshiquan sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway
AT houwugang sevofluranepreconditioningprotectsexperimentalischemicstrokebyenhancingantiinflammatorymicrogliamacrophagesphenotypepolarizationthroughgsk3bnrf2pathway